Verona pharma plc

Major-Pharmaceuticals

VRNA


3 More London Riverside
London , SE1 2RE

Executive/
Director

Price

  • Last Close
  • $ 46.69
    $ -1.54 -3.19 %
    Jan 3, 2025
  • 52-Week High/Low
  • $28 - $11.49
  • YTD
  • 0.4%

  • Trading Volume
  • 36,300
  • Market Cap Full
  • $ 29.9B
  • Shares Outstanding
  • 639.5M
    Oct 27, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - 68.5% -32.6% -5% 11.3% -25.7% -23.2% -19.3% 0.4%
Q2 - -13.6% -27.2% -20.6% 4% -16.1% -16% 5.3% -5.1% -
Q3 - 31.7% -9.4% -10.8% 8% -15.7% 143.9% -22.9% 14.6% -
Q4 - -24.4% -24.3% 23.4% 12.2% 21.9% 155.7% 28.5% 16.7% -
J F M A M J J A S O N D
2025 0.4% - - - - - - - - - - -
2024 -7.7% -6.2% -6.8% -1.9% -23.2% 25.9% 49% 14.6% - - - 17.3%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%-19%-42%25%-4%289%-24%134%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -1.6 -0.53 -0.93 -0.36 -0.4 -0.24
Q2 - 0.37 0.06 -0.88 -0.68 -0.4 -0.32 -0.08
Q3 - 0.91 -0.23 -0.95 -0.46 0.16 -0.24 -0.18
Q4 - 0.64 -0.25 -0.74 0.09 -0.3 -0.08 -
A 0 1.9 -2 -3.1 -1.98 -0.1 -0.1 -0.5

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2021 2022 2023
Mar - - 463.5 482.9 631.9
Jun - - 463.7 482.9 635.7
Sep - - 480.3 487.6 635.9
Dec 105.3 105.3 480.1 605 639.5

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - 2.7 - - -
Total Asset Turnover - 0.2 - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 10.9 4.3 8.2 4.7 4.9
Equity multiplier 0.1 0.1 - - -